Markets › India › NSE › GLAXO

GlaxoSmithKline Pharmaceuticals Ltd

NSE:GLAXOHealthcareNSE:CNX500NSE:NIFTY500_EW

₹2,495.40−2.76%At closeAt close · Mon 19 Oct · ≈ AED 96.28 · Market cap $4.57B · Next earnings Tue 3 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	53.8%	55.6%	57.9%	58.7%	60.5%	43.6%	—	—
Operating margin	17.9%	21.4%	23.2%	24.4%	29.9%	33.0%	33.0%	+0.0 pts
Net margin	12.4%	51.9%	18.9%	17.1%	24.9%	27.1%	27.1%	+0.0 pts
EBITDA margin	18.5%	26.0%	28.0%	25.8%	35.6%	38.6%	—	—
Return on equity	24.2%	63.6%	35.1%	33.2%	47.5%	45.7%	45.7%	+0.0 pts
Return on assets	11.5%	36.6%	18.4%	16.6%	22.6%	24.0%	24.0%	+0.0 pts
Return on capital employed	29.5%	23.8%	37.4%	41.3%	50.6%	49.5%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	1.1%	0.4%	0.5%	0.5%	0.2%	0.8%	—	—
Interest coverage	147.1×	350.1×	413.5×	466.2×	944.9×	461.5×	—	—
Current ratio	1.6×	2.2×	1.9×	1.8×	1.8×	2.0×	2.0×	+0.0%
Quick ratio	1.2×	1.9×	1.5×	1.5×	1.5×	1.8×	—	—
Cash ratio	0.3×	0.2×	0.0×	0.0×	0.3×	0.6×	0.6×	+0.0%
Asset turnover	0.9×	0.7×	1.0×	1.0×	0.9×	0.9×	—	—
Inventory turnover	2.4×	2.7×	3.0×	2.7×	3.1×	3.1×	—	—
Receivables turnover	12.0×	15.9×	9.8×	9.8×	10.3×	12.3×	—	—
Dividend payout	189.0%	29.9%	249.8%	91.8%	80.8%	68.9%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.